APA (7th ed.) Citation

Osinowo K, Sambo-Donga F, Ojomo O, Ibitoye SE, Oluwayemi P, Okunfulure M, . . . Ekholuenetale M. (2021). Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era. Dove Medical Press.

Chicago Style (17th ed.) Citation

Osinowo K, Sambo-Donga F, Ojomo O, Ibitoye SE, Oluwayemi P, Okunfulure M, Ladipo OA, and Ekholuenetale M. Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era. Dove Medical Press, 2021.

MLA (9th ed.) Citation

Osinowo K, et al. Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era. Dove Medical Press, 2021.